VSDH lists GLP-1 — the ops test decides the fit
VSDH's branded pharmacy network compounds semaglutide, tirzepatide, and related weight-loss SKUs across 503A and 503B partners. For a clinic evaluating suppliers, that catalog breadth is expected — every major hub lists GLP-1 today. VSDH's differentiated pitch is the full white-label stack: consumer apps, telemedicine, medical direction, and managed branded pharmacy for operators launching a new D2C weight-loss brand through ConnectRxCare or partner APIs.
For an existing cash-pay weight-loss clinic that already has patients, prescribers, and a brand, the question is not whether GLP-1 appears in the catalog. It is whether clinic-facing landed cost is visible before the consult, whether ConnectRxCare supports batching every patient due on refill day into one checkout, and whether orders validate before payment. VSDH wholesale pricing exists for partners, but clinic-facing economics are often wrapped in revenue-share agreements rather than self-serve pass-through quotes in cart.